82.9%
MepolizumabIL-5severe asthma
…crease (~8%) in methylation between baseline and 3 months among Mepolizumab responders, while non-responders exhibited an increase (~4%). A…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: IL-5 ×
IL-5
This drug is selected. Its supporting articles are shown below.